EPLEX BLOOD CULTURE IDENTIFICATION GRAM NEGATIVE (BCID-GN) PANEL
Report
- Report Number
- 3008632402-2025-01122
- Event Type
- Malfunction
- Date Received
- April 14, 2025
- Date of Event
- March 18, 2025
- Report Date
- May 2, 2025
- Manufacturer
- GENMARK DIAGNOSTICS, INC.
- Product Code
- PEN
- PMA / PMN Number
- K182619
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE GM EPLEX BASE UNIT SERIAL NUMBER WAS (B)(6). NO MALFUNCTION WAS FOUND FOR THE EPLEX INSTRUMENT, AND IT WAS WORKING WITHIN SPECIFICATION. THE INVESTIGATION IS ONGOING.
THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. ANTIMICROBIAL RESISTANCE CAN OCCUR VIA MULTIPLE MECHANISMS, AND THE BCID-GN PANEL IS DESIGNED TO DIRECTLY DETECT THE NUCLEIC ACID OF A RESISTANCE GENE. A 'NOT DETECTED' RESULT FOR AN ANTIMICROBIAL RESISTANCE GENE SHOULD NOT BE INTERPRETED AS ANTIMICROBIAL SUSCEPTIBILITY TO A SPECIFIC ORGANISM. IN ADDITION, ESBL RESISTANCE CAN BE DUE TO MECHANISMS OTHER THAN THE ACQUISITION OF THE CTX-M RESISTANCE GENE. A 'NOT DETECTED' FOR THE SPECIFIC CTX-M RESISTANCE GENE PRESENT IN THE E. COLI MAY BE DUE TO SEQUENCE VARIATION AND/OR ASSAY LIMITATION.
THERE WAS AN ALLEGATION OF FALSE NEGATIVE CTX-M RESULT WHILE USING THE EPLEX BLOOD CULTURE IDENTIFICATION GRAM NEGATIVE (BCID-GN) PANEL ON A GM EPLEX BASE UNIT. THE RESULT FROM THE EPLEX WAS NO DETECTION FOR ANY OF THE RESISTANCE GENES AND DETECTED FOR E. COLI. THE CULTURE RESULT WAS E. COLI. EXTENDED-SPECTRUM BETA-LACTAMASES (ESBL) WAS CONFIRMED USING PHOENIX ESBL TEST. REFER TO THE ATTACHMENT TO MEDWATCH FOR THE SUSCEPTIBILITY TESTING RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1080542 | EPLEX BLOOD CULTURE IDENTIFICATION GRAM NEGATIVE (BCID-GN) PANEL | GRAM-NEGATIVE BACTERIA AND ASSOCIATED RESISTANCE MARKERS | PEN | GENMARK DIAGNOSTICS, INC. | 10230394 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 57 YR | Female |